• CHMP Appoints New Vice-Chair

    The European Medicines Agency (EMA) has appointed Ian Hudson as the new vice-chair of its Committee for Medicinal Products for Human Use (CHMP) after its previous vice-chair was appointed to the position of chair of the CHMP. Hudson ( PDF ) has been a member of the CHMP since 2004, and has also served on the Paediatric Committee (PDCO), the Committee for Proprietary Medicinal Products (CPMP) and the guideline consistency group. Outside of EMA's advisory groups, he curr...
  • CHMP Elects New Leader after Atypical Transition

    The European Medicines Agency (EMA), currently in the midst of a number of changes in committee staff, has elected Thomas Salmonson as the new chair of its influential Committee for Medicinal Products for Human Use (CHMP). CHMP's transition has been anything but typical. Its previous chair, Eric Abadie, resigned abruptly in April 2012 after being linked to a scandal involving then-French-regulator Afssaps's handling of the anti-diabetes drug Mediator . French regu...
  • New French Regulatory Agency Announces Transition of Leadership

    • 03 May 2012
    France's newly-formed National Agency for the Safety of Medicines and Health Products (MSNA), which will ostensibly replace Afssaps, announced 5 May that it will retain its existing leader, Dominique Maraninchi, for the new agency. Maraninchi will lead the new agency, established 1 May by decree, after only having been at Afssaps since February 2011. The agency has been under fire for a number of scandals, including the revelations that the agency allowed Servier's diab...
  • EMA Looks to Open Up Clinical Trial Data After Concerns About Tamiflu Raised

    The European Medicines Agency (EMA) announced it is looking to develop a "way forward for publication of full clinical trial data" after concerns were published about selective publication of Tamiflu efficacy data. Tamiflu, which was stockpiled heavily around 2009 due to fears about swine flu, was recently attacked in the medical journal PLoS Medicine by authors Peter Doshi, Tom Jefferson and Chris Del Mar, who claim the drug overstated its effectiveness by hiding cert...
  • UPDATED (2): EMA's Abadie Resigns as Chair of CHMP

    The European Medicines Agency (EMA) announced 4 April that effective immediately, Eric Abadie, chair of the Committee for Medicinal Products for Human Use (CHMP), was resigning from his position. "Executive Director Guido Rasi has accepted his resignation with immediate effect," wrote EMA in a press release. In a statement to Reuters , a spokesman said the move was related to Abadie's position at French regulatory authority Afssaps , where he serves as a scientific ad...